Meth blister pack bill
This article was originally published in The Tan Sheet
Executive Summary
Blister-packed pseudoephedrine products would be subject to 9 gram retail sales limit applied to bottled products under "Methamphetamine Blister Pack Loophole Elimination Act of 2003" (S 1784) introduced Oct. 22 by Sen. Dianne Feinstein. Bill cites 2002 DEA study recommending limit, noting presence of blister packs at meth labs. Feinstein and others have introduced similar measures in the past. CHPA continues to object to uniform 9 g threshold, saying limit will not prevent diversion of products to labs. Bill was referred to Senate Judiciary Committee...
You may also be interested in...
Pseudoephedrine blister-pack bill
"Methamphetamine Blister Pack Loophole Elimination Act of 2003" (S 1784) was reported without amendment out of Senate Judiciary Committee and placed on the legislative calendar. Introduced by Sen. Dianne Feinstein (D-Calif.) a year ago, the measure would limit sales of pseudoephedrine to a 9 g threshold in an attempt to curb diversion of the ingredient to meth labs (1"The Tan Sheet" Oct. 27, 2003, In Brief). CHPA consistently has opposed similar bills, maintaining the limit will not prevent diversion and will harm retailers...
DEA Rule On Pseudoephedrine Limit “At Odds” With Meth Law - CHPA
A Drug Enforcement Administration "interpretive rule" on purchase amount limits for pseudoephedrine products conflicts with current methamphetamine control law, according to the Consumer Healthcare Products Association
Meth bill
"Methamphetamine Blister Pack Loophole Elimination Act of 2004" (HR 3789), introduced in House Feb. 10 by Collin Peterson (D-Minn.), mirrors bill introduced by Sen. Dianne Feinstein (D- Calif.). Bill would eliminate exemption for blister-pack pseudoephedrine products from 9 g sales limit on bottled products (1"The Tan Sheet" Oct. 27, 2003, In Brief)...